EyePoint Pharmaceuticals, Inc. (EYPT)
17.08
-0.74
(-4.15%)
USD |
NASDAQ |
Dec 09, 16:00
17.06
-0.02
(-0.12%)
Pre-Market: 08:55
EyePoint Pharmaceuticals EPS Diluted (Quarterly): -0.8513 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Agios Pharmaceuticals, Inc. | -1.779 |
| Viking Therapeutics, Inc. | -0.8083 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.73M |
| Revenue (Quarterly) | 0.966M |
| Total Expenses (Quarterly) | 60.70M |
| Enterprise Value | 1.233B |
| Gross Profit Margin (Quarterly) | 25.36% |
| Profit Margin (Quarterly) | -6.18K% |
| Earnings Yield | -17.51% |
| Normalized Earnings Yield | -17.51 |